TriSalus Life Sciences (TLSI) Return on Capital Employed (2021 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Return on Capital Employed of 67.75% for Q1 2026, up 15103.0% year-over-year from N/an in Q1 2025, and up 38.66% quarter-over-quarter from 110.44% in Q4 2025.
TriSalus Life Sciences (TLSI) Return on Capital Employed (2021 - 2026) Analysis & Trends
TriSalus Life Sciences' Return on Capital Employed history runs 6 years deep, the most recent figure standing at 67.75% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 15103.0% year-over-year to 67.75%; the TTM figure through Mar 2026 stood at 67.75% (up 15103.0% YoY), while the FY2025 annual figure was 148.45%, up 10884.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 67.75%, up from 110.44% in the prior quarter.
- The five-year high for Return on Capital Employed was 1.17% in Q2 2022, with the low at 817.14% in Q1 2024.
- The 5-year median for Return on Capital Employed is 182.56% (2023), against an average of 215.54%.
- The sharpest annual moves came in 2024 and 2025: Return on Capital Employed plunged 63458 bps in 2024, then soared 59836 bps in 2025.
- TriSalus Life Sciences' Return on Capital Employed stood at 19.98% in 2022, then tumbled by 1793 bps to 378.2% in 2023, then jumped by 38 bps to 233.38% in 2024, then jumped by 53 bps to 110.44% in 2025, then surged by 39 bps to 67.75% in 2026.
- Business Quant data shows TLSI's Return on Capital Employed at 67.75% in Q1 2026, 110.44% in Q4 2025, and 111.7% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 12.08% |
| 10 | TriSalus Life Sciences | 306.64 Mn | 260.35 Mn | 9.90 Mn | -54.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -54.93% |
| Mar 31, 2026 | -67.75% |
| Dec 31, 2025 | -110.44% |
| Sep 30, 2025 | -111.70% |
| Jun 30, 2025 | -120.79% |
| Mar 31, 2025 | -218.78% |
| Dec 31, 2024 | -233.38% |
| Sep 30, 2024 | -213.78% |
| Jun 30, 2024 | -400.44% |
| Mar 31, 2024 | -817.14% |
| Dec 31, 2023 | -378.20% |
| Sep 30, 2023 | -382.19% |
| Jun 30, 2023 | -400.46% |
| Mar 31, 2023 | -182.56% |
| Dec 31, 2022 | -19.98% |
| Sep 30, 2022 | -4.10% |
| Jun 30, 2022 | -1.17% |
| Mar 31, 2022 | -1.37% |
| Dec 31, 2021 | -1.22% |